Browsing Category
Sectors
619 posts
UK Biotech Antiverse Secures $9.3M to Target Hard to Drug Disease Proteins
Drug discovery has made enormous progress over the past decades, yet many diseases remain difficult to treat because…
baCta Raises €7M to Program Microbes as Factories for Industrial Ingredients
Paris based industrial biotechnology startup baCta has secured €7 million in seed funding to accelerate the development of…
Are French AI Models a Real Challenger to OpenAI?
Dive into the 2026 data driving the Paris AI ecosystem. We investigate how Mistral AI, Kyutai, and data sovereignty are creating a legitimate European alternative to OpenAI.
VivaTech’s Promise: Tracking the ROI of France’s Public Deep Tech Investment
We track the true ROI of the French Tech initiative and the France 2030 plan. Discover the success metrics and tech-transfer bottlenecks defining the Parisian deep-tech boom.
Why Europe’s AI Application Layer Isn’t a Real Moat
The European artificial intelligence sector is currently paralysed by the moat question. General Partners sitting in Mayfair and…
Qura Wants to Catch Health Problems Before They Become Illness
Preventive healthcare in Europe is gaining momentum, yet millions of people continue to fall through the cracks of…
Outpost Bio Raises $3.5M to Build AI Driven Models for Human Microbiology
Understanding human biology has long focused on genes and isolated biological components, but many of the most critical…
Oska Health Secures €11M Seed Round to Expand Hybrid AI and Human Care Model
Oska Health, a hybrid care provider combining human health coaching with AI-enabled support, has raised €11 million in…
Kinfolk Raises $7.2M to Replace HR Tickets and Chatbots With Autonomous AI
London based Kinfolk is betting that the future of HR will not be managed through tickets or chatbots…
Ireland New Unicorn Factory: The SaaS Founders Quietly Building Global B2B Giants
Discover how native Irish founders are building the next generation of global B2B SaaS unicorns. We profile startups like Tines and Nory targeting the US enterprise market.